Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma
Condition(s):AsthmaLast Updated:February 24, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):AsthmaLast Updated:February 24, 2023Recruiting
Condition(s):Crohn DiseaseLast Updated:October 6, 2023Recruiting
Condition(s):Hearing Loss, SuddenLast Updated:July 13, 2022Recruiting
Condition(s):Lumbar Spine Disc Herniation; Lumbar RadiculopathyLast Updated:March 10, 2020Completed
Condition(s):Glomerulonephritis; IgANLast Updated:January 20, 2021Terminated
Condition(s):B Lymphoblastic LeukemiaLast Updated:March 28, 2024Recruiting
Condition(s):CoronavirusLast Updated:April 18, 2023Completed
Condition(s):Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Adult L1 Acute Lymphoblastic Leukemia; Adult L2 Acute Lymphoblastic Leukemia; Adult T Acute Lymphoblastic Leukemia; Recurrent Adult Acute Lymphoblastic LeukemiaLast Updated:February 26, 2024Active, not recruiting
Condition(s):Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Last Updated:April 13, 2020Completed
Condition(s):Classical Hodgkin LymphomaLast Updated:July 27, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.